Autentificare
NeuroPsy InfoHubÎnțelege · Sprijin · ProgresCere sprijin

Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Începe gratuitSunt părinteSunt specialist
Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

AutismSpectrul autist și particularitățile asociate.223 de articole
ADHDAtenție, impulsivitate și hiperactivitate.202 articole
Sindrom DownDezvoltare și sprijin pentru sindromul Down.57 de articole
AnxietateÎngrijorare excesivă, tensiune, atacuri de panică.73 de articole
DepresieTristețe persistentă, lipsa energiei și a motivației.106 articole
AdicțiiDependențe de substanțe și comportamentale.135 de articole

Afecțiuni neurologice

DemențeBoala Alzheimer și alte forme de demență.73 de articole
AVC și AITAccident vascular cerebral și recuperare, la orice vârstă.64 de articole
Leziuni medulareLeziuni medulare, paraplegie și tetraplegie.55 de articole
EpilepsieCrize epileptice și managementul lor.127 de articole
ParkinsonBoala Parkinson și tulburări de mișcare.64 de articole
Scleroză multiplăScleroza multiplă și viața cu aceasta.71 de articole
Traumatisme cranio-cerebraleTraumatisme cranio-cerebrale și recuperare.81 de articole

Articole și ghiduri recomandate

PublicToțiPentru oricineSpecialiști
VârstăToate vârsteleCopiiTineriAdulțiVârstnici
StudiuAutism + ADHDÎncredere bună21.06.2026

Relationship between depression and sex steroid hormones in women with epilepsy

This study investigated associations between sex steroid hormones, antiseizure medications, and depression in 112 women with epilepsy compared to 50 healthy controls, finding a 18.8% depression prevalence and significant hormonal differences including elevated testosterone and altered FSH, estradiol, progesterone, and prolactin levels. Sex steroid hormones emerge as potential biomarkers for depression risk in women with epilepsy, with implications for treatment and prognosis.

StudiuAutism + ADHDÎncredere bună21.06.2026

Neuropsychiatric Disorders and Burn Trauma: Clinical Epidemiology from a Tertiary Hospital

A prospective observational study over 24 months analyzed burn injury characteristics in patients with underlying neuropsychiatric conditions, finding epilepsy as the most common disorder (66.52%) followed by intellectual disability and dementia. Female patients experienced higher rates of severe burns and scalding injuries with more frequent third-degree burns and head/neck involvement compared to males.

StudiuAutism + ADHDÎncredere bună21.06.2026

Psychiatric Comorbidities in Functional Neurological Disorders and Psychogenic Non-Epileptic Seizures: Systematic Review and Policy Recommendations

This systematic review examines psychiatric comorbidities associated with Functional Neurological Disorders (FND) and Psychogenic Non-Epileptic Seizures (PNES), finding these are not autonomous conditions but develop alongside autism, borderline personality disorder, PTSD, and alexithymia. The authors propose a biopsychosocial model where early trauma, abuse, and neglect contribute to progressive neurological sensitivity, particularly in young female patients, and recommend improved assessment and integrated treatment policies.

StudiuAutism + ADHDÎncredere bună21.06.2026

Anxiety and Depression after Spinal Cord Injury: A Cross-Sectional Study

This study examined the prevalence of depression and anxiety in individuals with subacute and chronic spinal cord injury using validated psychological assessment tools (BDI and STAI scales). Results showed significant alterations in both depression and anxiety levels, with differences noted between subacute and chronic phases; early psychological assessment and intervention are recommended to prevent cognitive and mental health complications.

StudiuAutism + ADHDÎncredere înaltă21.06.2026

Epileptic variant in the spectrum of Alzheimer's disease - practical implications

Alzheimer's disease carries increased epilepsy risk not only in advanced stages but also during mild cognitive impairment and preclinical stages, with seizures sometimes being the earliest clinical manifestation (epileptic variant of AD). This presentation offers a therapeutic window where antiseizure medications may help prevent cognitive decline by addressing AD-related brain hyperexcitability, but requires biomarker assessment (amyloid and tau) for accurate diagnosis.